#ADA26: Roche's incretin shot works in mid-stage trial in type 1 diabetes

June 5, 2026 06:30 PM EDT R&D Roche’s in­cretin shot works in mid-stage tri­al in type 1 di­a­betes Elizabeth Cairns Senior biopharma journalist A dai­ly in­cretin shot be­ing de­vel­oped by Roche has shown promise in type 1 di­a­betes — the form that is not gen­er­al­ly be­lieved to be di­rect­ly … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER